These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2577399

  • 1. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K, de Fijter CW, Bos HJ, van der Meulen J, Beelen RH, Oe PL, Verbrugh HA.
    Adv Perit Dial; 1989; 5():151-3. PubMed ID: 2577399
    [Abstract] [Full Text] [Related]

  • 2. Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients.
    Vlaanderen K, Bos HJ, de Fijter CW, Oe LP, van der Meulen J, Verbrugh HA, Beelen RH.
    Nephron; 1991; 57(1):29-35. PubMed ID: 2046812
    [Abstract] [Full Text] [Related]

  • 3. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW, Verbrugh HA, Heezius HC, van Bronswijk H, van der Meulen J, Oe PL, Donker AJ, Verhoef J.
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [Abstract] [Full Text] [Related]

  • 4. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ, Brock JH, Briggs JD, Junor BJ.
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [Abstract] [Full Text] [Related]

  • 5. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M, Blaim M, Kolewska D, Janota-Krawczyk E, Tomaszewska-Pańczyk M, Sieniawska M.
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [Abstract] [Full Text] [Related]

  • 6. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function.
    Alobaidi HM, Coles GA, Davies M, Lloyd D.
    Nephrol Dial Transplant; 1986; 1(1):16-21. PubMed ID: 3110659
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
    de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Verhoef J, Donker AJ.
    Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.
    de Fijter CW, Verbrugh HA, Oe PL, Peters ED, van der Meulen J, Donker AJ, Verhoef J, Lameire N.
    Adv Perit Dial; 1991 Feb; 7():154-7. PubMed ID: 1680414
    [Abstract] [Full Text] [Related]

  • 14. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ, Yewdall VM, Ogg CS, Cameron JS.
    Perit Dial Int; 1990 Feb; 10(2):135-40. PubMed ID: 2085598
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages.
    Steinhauer HB, Brugger U, Atmanspacher R, Lubrich-Birkner I, Schollmeyer P.
    Adv Perit Dial; 1992 Feb; 8():47-52. PubMed ID: 1361851
    [Abstract] [Full Text] [Related]

  • 17. Effect of glucose concentration and dwell time of dialysis fluid on the antibacterial defense in the peritoneal cavity of rats.
    Calame W, Hendrickx RJ, Oe LP, Namavar F, Beelen RH.
    Adv Perit Dial; 1992 Feb; 8():219-22. PubMed ID: 1361790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis.
    Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, Peterson PK.
    J Infect Dis; 1983 Jun; 147(6):1018-29. PubMed ID: 6854062
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.